Document is current
Any future updates will be listed below
-
Authors
Lin, Meixuan
Xu, Xiaoqiang
Zhou, Xiaoman
Feng, Hui
Wang, Ruili
Yang, Yunyun
Li, Jing
Fan, Ning
Jiang, Yazhuo
Li, Xiang
Guan, Feng
Tan, Zengqi https://orcid.org/0000-0002-2268-6248
-
Funding
Funding for this research was provided by:
National Science Foundation of China (32271338, 31971211, 32071274, 81802654, 32101031)
Science Foundation for Distinguished Young Scholars of Shaanxi Province (2021JC-39)
Natural Science Foundation of Shaanxi Province (2021SF-294)
Shaanxi Innovation Team Project (2023-CX-TD-58)
Shaanxi Fundamental Science Research Project for Chemistry & Biology (22JHQ077)
- License Information
-
More Information
Article History
Received: 2 November 2023
Accepted: 20 March 2024
First Online: 1 April 2024
Declarations
:
: The above human plasma study was conducted in accordance with the Declaration of Helsinki and was approved by the Medical Ethics Committee of the Northwest University (approval number: 220224018, 24 February 2022), plasma samples were obtained from bladder cancer patients at Provincial People’s Hospital, Shaanxi, China. Written informed consent was obtained from all patients. All mouse experiments were performed in accordance with the Basel Declaration and approved by the Animal Care and Use Committee of Northwest University (approval number: NWU-AWC-20211201 M, 4 December 2021), and were performed under ARRIVE (Animal Research: Reporting of in vivo Experiments) guidelines.
: Not applicable.
: The authors declare that they have no competing interest.
